Shares of ResMed Inc. RMD advanced 1.25% to $251.69 Friday, on what proved to be an all-around favorable trading session for ...

Shares of ResMed Inc. RMD rallied 1.07% to $247.66 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to 5,844.19 and the ...

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home ...

Readers hoping to buy ResMed Inc. ( NYSE:RMD ) for its dividend will need to make their move shortly, as the stock ...

Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call.

Greetings, and welcome to the Q3 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. At this time, all participants are in a listen-only ...

J.P. Morgan analyst David Low maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) on April 24 and set a pri ...

We recently published a list of Jim Cramer Says The Day “Everything’s A Lot More Expensive” Is Coming & Discusses These 10 Stocks. In this article, we are going to take a look at where Resmed Inc ...

Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen ratings firms that are covering the stock, MarketBeat reports.

Looking at the universe of stocks we cover at Dividend Channel, on 5/8/25, Seaboard Corp. (Symbol: SEB), KB Home (Symbol: KBH), and ResMed Inc. (Symbol: RMD) will all trade ex-dividend for their ...

Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2025. Revenue increased by 8% to $1.3 billion; up 9% on a constant currency basis Gross margin improved ...

Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Greetings, and welcome to the Q3 fiscal year 2025 ResMed earnings conference call. My name is Kevin, and I'll be your operator for today's call.